BIOMAT Database Logo BIOMAT Database Logo

Heparanase messenger RNA expression in epithelial ovarian tumor. 2003

Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Department of Obstetrics and Gynecology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. kodama@cc.okayama-u.ac.jp

Endoglycosidic heparanase degrades heparan sulfate glycosaminoglycans, and may be important in cancer invasion and metastasis, although its expression in human epithelial ovarian cancer has not been characterized. Heparanase association with clinicopathological features regarding prognostic significance was examined in patients presenting with epithelial ovarian tumor. Gene expression of heparanase was assessed by reverse transcription-PCR in 5 borderline and 31 malignant epithelial ovarian tumors. Heparanase mRNA expression was high in 16 of 31 malignant epithelial ovarian tumors. In contrast, there was no specimen presenting high heparanase mRNA expression in five borderline epithelial ovarian tumors. Heparanase expression was significantly higher in tumors with massive ascites and high grade (p=0.049 and p=0.006, respectively). There was no association between heparanase expression and patient outcome. These findings provide evidence that heparanase expression may be associated with a high grade phenotype in this class of neoplasm.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D005966 Glucuronidase Endo-beta-D-Glucuronidase,Endoglucuronidase,Exo-beta-D-Glucuronidase,beta-Glucuronidase,Endo beta D Glucuronidase,Exo beta D Glucuronidase,beta Glucuronidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D020133 Reverse Transcriptase Polymerase Chain Reaction A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols. Polymerase Chain Reaction, Reverse Transcriptase,Reverse Transcriptase PCR,PCR, Reverse Transcriptase,Transcriptase PCR, Reverse

Related Publications

Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
January 2001, Anticancer research,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma.
November 2002, Journal of surgical oncology,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
October 2005, Gynecologic oncology,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Expression of tumor necrosis factor alpha-induced protein 6 messenger RNA in porcine preovulatory ovarian follicles.
June 2009, The Journal of reproduction and development,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype.
August 2022, The Journal of clinical investigation,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells.
April 1994, Gynecologic oncology,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Expression of neurotensin messenger RNA in a human carcinoid tumor.
October 1991, Annals of surgery,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA.
August 2002, Critical care medicine,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
MicroRNA and Messenger RNA Expression Profiles in Canine Mammary Gland Tumor.
January 2023, International journal of molecular sciences,
Junichi Kodama, and Yasuhiro Shinyo, and Gaowa Hashen, and Atsushi Hongo, and Mitsuo Yoshinouchi, and Yuji Hiramatsu
Expression of neurotensin messenger RNA in a human pancreatic carcinoid tumor.
January 1992, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!